Local anesthesia thoracoscopy for diagnosing pleural effusion

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of Local Anesthesia Thoracoscopy (LAT) as a first-line diagnostic tool for patients with suspected malignant pleural effusion. It compares outcomes between patients undergoing LAT and those receiving standard diagnostic procedures, which typically involve multiple cytological tests before biopsy. The study aims to assess the efficacy, sensitivity, hospitalization duration, time to diagnosis, and overall safety and comfort of both approaches. By streamlining the diagnostic process, the study seeks to improve patient outcomes and reduce delays in treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Undiagnosed pleural effusion with the character of a lymphocytic exudate

Exclusion Criteria:

* Empyema
* Transudate pleural effusion.
* Central airway obstruction by tumor.
* Existence of extensive adhesions that do not allow the development of iatrogenic pneumothorax and the safe entry of the thoracoscope.
* Uncontrollable cough.
* Acute respiratory failure and/or Hypercapnia.
* Performance Status: 5

Where it's running

• Sotiria General Hospital of Thoracic Diseases
  Athens, Attica, Greece Recruiting

Study contacts

• Study coordinator: Nektarios ANAGNOSTOPOULOS, Ass. professor
• Email: aris.anag@yahoo.gr
• Phone: +306946869480

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Feasibility of a disposable flexible bronchoscope for thoracoscopy compared with a semi-rigid pleuroscope in pleural effusion

  This study tests whether a single-use flexible bronchoscope can be used safely and effectively for medical thoracoscopy in patients with pleural effusion, compared with the standard semi-rigid pleuroscope.

  Recruiting at 2 sites National University of Malaysia · Kuala Lumpur, Kuala Lumpur and 1 other locations · NCT07726784

• Fast TIL therapy for cancers that have spread to the pleura, including mesothelioma

  This study will try a patient's own pleural T cells grown briefly in the lab and given into the chest with local IL-2 to treat people with malignant pleural effusions or pleural mesothelioma who have exhausted standard treatments.

  Recruiting Phase 1 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07443020

• Bubble PEP plus Segmental Breathing versus Incentive Spirometry for children with pleural effusion

  This trial will test whether bubble positive expiratory pressure with segmental breathing helps children aged 5–16 with pleural effusion breathe better than incentive spirometry.

  Recruiting Riphah International University · Lahore, Punjab Province · NCT07248774

• Fast TIL therapy for cancers that have spread to the pleura

  This treatment will try a patient's own pleural T cells, grown quickly in the lab and given into the chest with local IL-2, for adults whose cancer has spread to the pleura or for pleural mesothelioma.

  Recruiting Phase 1 Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Pittsburgh, Pennsylvania · NCT07192900

• Partial pleurectomy to relieve symptoms from unresectable pleural mesothelioma.

  The team will try a limited partial pleurectomy and decortication to reduce chest symptoms and improve quality of life for people with epithelioid pleural mesothelioma that cannot be completely removed.

  Recruiting University of Chicago · Chicago, Illinois · NCT07126509

• Once-daily intrapleural enzyme treatment for complicated pleural infections

  This will see if giving tPA and DNase once a day through a chest tube works as well as giving them twice a day for people with complicated pleural infections.

  Recruiting at 11 sites Phase 4 University of North Carolina, Chapel Hill · Little Rock, Arkansas and 10 other locations · NCT07095361

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.